3-Propenzl cephalosporin isomer separation process and derivative
AssigneeBristol-Myers Company
InventorsMurray A. Kaplan, Michael W. Lovell, Joseph B. Bogardus
Life of this patent
Estimating the term…
Abstract
The antibiotic 7-[D-2-amino-2-(4-hydroxyphenyl)acetamido]-3-[(Z)-1-propenyl]ceph-3-em-4-c arboxylic acid (BMY-28100) forms imidazolidinone derivatives on reaction with ketones. These derivatives are useful in pharmaceutical dosage forms and as intermediates for separation thereof from mixtures containing the [(E)-1-propenyl]isomer of the antibiotic.
Claims21
The process for preparing and separating antibiotic sodium salt imidazolidinone derivative which comprises (1) contacting a composition containing the antibiotic 7-[D-2-amino-2-(4-hydroxyphenyl)acetamido]-3-[(Z)-1-propenyl]ceph-3-em-4-c arboxylic acid in admixture with the (E)-isomer thereof with a sodium salt forming reagent in the presence of an alkyl, alicyclic, aryl, or aralkyl ketone having a molecular weight of less than 200 under reaction conditions whereby antibiotic sodium salt imidazolidinone derivative and (E)-isomer sodium salt imidazolidinone derivative are formed (2) suspending the imidazolidinone derivatives formed in Step (1) in a solvent in which said (E)-isomer sodium salt imidazolidinone derivative is soluble and said antibiotic sodium salt imidazolidinone derivative is substantially insoluble thereby forming a suspension of said antibiotic derivative in a solution of said (E)-isomer derivative, and (3) recovering said insoluble antibiotic derivative from said suspension substantially free of said (E)-isomer derivative.
The 3-[(Z)-1-propenyl]cephalosporin imidazolidinone derivative having the formula ##STR10## wherein R and R.sup.1 are the organic groups of an alkyl, alicyclic, aryl, or aralkyl ketone having the formula ##STR11## or they are joined to form a alicyclic ketone, said ketone having a molecular weight of up to 200, a pharmaceutically acceptable metal or amine salt thereof, or a crystalline solvate of said acid or said salt with a pharmaceutically acceptable liquid.
Dependencies are inferred from the claim text.